When is a cancer drug too pricey?

ASCO is holding a panel discussion on how oncologists can or should take cost into account when prescribing cancer treatments. A very, very important topic. From the article"…the high prices on many cancer drugs are unsustainable, so the organization wants to provide oncologists with a scorecard they can use to determine when the benefits of a drug don't justify its cost."

At the level of the individual, cost should not be a factor when deciding on cancer treatments. At the level of the society, cost is the inescapable elephant in the room. I hope will all be watching the news reports on this panel discussion and this whole ASCO initiative. 

ASCO is holding a panel discussion on how oncologists can or should take cost into account when prescribing cancer treatments. A very, very important topic. From the article"…the high prices on many cancer drugs are unsustainable, so the organization wants to provide oncologists with a scorecard they can use to determine when the benefits of a drug don't justify its cost."

At the level of the individual, cost should not be a factor when deciding on cancer treatments. At the level of the society, cost is the inescapable elephant in the room. I hope will all be watching the news reports on this panel discussion and this whole ASCO initiative. 

ASCO is holding a panel discussion on how oncologists can or should take cost into account when prescribing cancer treatments. A very, very important topic. From the article"…the high prices on many cancer drugs are unsustainable, so the organization wants to provide oncologists with a scorecard they can use to determine when the benefits of a drug don't justify its cost."

At the level of the individual, cost should not be a factor when deciding on cancer treatments. At the level of the society, cost is the inescapable elephant in the room. I hope will all be watching the news reports on this panel discussion and this whole ASCO initiative.